Blocking mitochondrial leucine transamination enhances T-cell activation and improves T-cell immunity against OVA-producing EL4 lymphoma. - Adam, Christie M.; Wetzel, Tanner J.; Erfan, Sheila C.; Wheeler, Leighton M.; Baer, Emily E.; Croll, Lindsey P.; Martin, Alexander M.; Khan, Taha Z.; Swain, Max L.; Boyer, Michael P.; Ananieva, Elitsa A. (British Journal of Cancer, 2026)